{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:09:23Z","timestamp":1789495763134,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Autologous hematopoietic stem-cell transplantation (HSCT) is the standard of care in many relapsed and refractory lymphoid malignancy, neuroblastoma, and multiple myeloma (MM). This study was conducted to describe the epidemiology of early infections that occurred within the first 100\u00a0days among patients who received HSCT for MM, Hodgkin (HL), and non-Hodgkin lymphoma (NHL) in Palestine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was conducted in a retrospective cohort design in the only autologous HSCT in Palestine in the period between 2014 and 2021. The medical records of the patients were reviewed to identify and collect demographic, clinical, and microbiological data on bacterial, viral, fungal, and parasitic infections as diagnosed by cultures, polymerase chain reaction, and fluorescent antibody testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 145 patients were included in this study (median age\u2009=\u200944.0 [28.0, 53.5] years). Of those, 8 (5.5%) were younger than 18\u00a0years, 69 (47.6%) had MM, 53 (36.6%) had HL, and 23 (15.9%) had NHL. The source of fever had no focus in the majority of the cases 82 (56.6%), 12 (8.3%) had bloodstream infections, 8 (5.5%) had colitis, and 7.6 (5.0%) had pneumonia. Patients from whom gram-negative bacteria were isolated stayed in the hospital for longer duration compared to the other patients (median\u2009=\u200921.0 [19.0, 25.0] vs. 18.0 [15.0, 22.0] days, p-value\u2009=\u20090.043, respectively). The cumulative incidence of death in the first 100\u00a0days after infusion of stem cells was 3.4%. The cumulative incidence of death in the first 100\u00a0days post-transplantation was higher for patients with NHL compared to those with HL and MM (p-value\u2009=\u20090.017). Gram-negative and fungal infections were strong predictors of mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Bacterial gram-positive and gram-negative infections were the most common early infections among patients who underwent autologous HSCT for hematological malignancies (HM) in the only center in Palestine. The findings of this study are informative to healthcare providers and planners of care for patients who are scheduled to receive autologous HSCT for HM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07709-4","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:05:30Z","timestamp":1662548730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine"],"prefix":"10.1186","volume":"22","author":[{"given":"Riad","family":"Amer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Mosleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Abu-Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Hamayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Enaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Adas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Khursani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Wild-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Battat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Daifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Koni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Shawahna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"issue":"8","key":"7709_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/07853890.2014.952662","volume":"46","author":"M Hamadani","year":"2014","unstructured":"Hamadani M. Autologous hematopoietic cell transplantation: an update for clinicians. Ann Med. 2014;46(8):619\u201332.","journal-title":"Ann Med"},{"issue":"4","key":"7709_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccm.2017.07.001","volume":"38","author":"N Singh","year":"2017","unstructured":"Singh N, Loren AW. Overview of hematopoietic cell transplantation for the treatment of hematologic malignancies. Clin Chest Med. 2017;38(4):575\u201393.","journal-title":"Clin Chest Med"},{"issue":"1","key":"7709_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ejh.12362","volume":"94","author":"K Hubel","year":"2015","unstructured":"Hubel K, de la Rubia J, Azar N, Corradini P. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J Haematol. 2015;94(1):12\u201322.","journal-title":"Eur J Haematol"},{"issue":"6","key":"7709_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/bmt.2016.20","volume":"51","author":"JR Passweg","year":"2016","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51(6):786\u201392.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"7709_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.bbmt.2007.09.006","volume":"13","author":"K Rao","year":"2007","unstructured":"Rao K, Darrington DL, Schumacher JJ, Devetten M, Vose JM, Loberiza FR Jr. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence. Biol Blood Marrow Transplant. 2007;13(12):1508\u201314.","journal-title":"Biol Blood Marrow Transplant"},{"key":"7709_CR6","unstructured":"Sheets WSAF: The Global Cancer Observatory. International Agency for Research on Cancer 2021."},{"issue":"6","key":"7709_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"7709_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204914","volume":"13","author":"S Hierlmeier","year":"2018","unstructured":"Hierlmeier S, Eyrich M, Wolfl M, Schlegel PG, Wiegering V. Early and late complications following hematopoietic stem cell transplantation in pediatric patients\u2014a retrospective analysis over 11 years. PLoS ONE. 2018;13(10): e0204914.","journal-title":"PLoS ONE"},{"issue":"4","key":"7709_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13114","volume":"21","author":"S Rahman","year":"2019","unstructured":"Rahman S, Rybicki L, Ky Hamilton B, Pohlman B, Jagadeesh D, Cober E, Kalaycio M, Dean R, Sobecks R, Mossad SB, et al. Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma. Transplant Infect Dis. 2019;21(4): e13114.","journal-title":"Transplant Infect Dis"},{"issue":"10","key":"7709_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/myc.12968","volume":"62","author":"C Linke","year":"2019","unstructured":"Linke C, Tragiannidis A, Ahlmann M, Frohlich B, Waltermann M, Burkhardt B, Rossig C, Groll AH. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center. Mycoses. 2019;62(10):954\u201360.","journal-title":"Mycoses"},{"issue":"10","key":"7709_CR11","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.bbmt.2013.07.022","volume":"19","author":"CD Alonso","year":"2013","unstructured":"Alonso CD, Dufresne SF, Hanna DB, Labbe AC, Treadway SB, Neofytos D, Belanger S, Huff CA, Laverdiere M, Marr KA. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood Marrow Transplant. 2013;19(10):1502\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"7709_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13225","volume":"22","author":"J Signorelli","year":"2020","unstructured":"Signorelli J, Zimmer A, Liewer S, Shostrom VK, Freifeld A. Incidence of febrile neutropenia in autologous hematopoietic stem cell transplant (HSCT) recipients on levofloxacin prophylaxis. Transplant Infect Dis. 2020;22(2): e13225.","journal-title":"Transplant Infect Dis"},{"issue":"1","key":"7709_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13610","volume":"24","author":"A Youssef","year":"2020","unstructured":"Youssef A, Hafez H, Madney Y, Elanany M, Hassanain O, Lehmann LE, El Haddad A. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations. Pediatr Transplant. 2020;24(1): e13610.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"7709_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","volume":"55","author":"J Styczynski","year":"2020","unstructured":"Styczynski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):126\u201336.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"7709_CR15","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","volume":"56","author":"A Esquirol","year":"2021","unstructured":"Esquirol A, Pascual MJ, Kwon M, Perez A, Parody R, Ferra C, Garcia Cadenas I, Herruzo B, Dorado N, Hernani R, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2021;56(10):2432\u201344.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"7709_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00277-020-04297-8","volume":"100","author":"M Christopeit","year":"2021","unstructured":"Christopeit M, Schmidt-Hieber M, Sprute R, Buchheidt D, Hentrich M, Karthaus M, Penack O, Ruhnke M, Weissinger F, Cornely OA, et al. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2021;100(2):321\u201336.","journal-title":"Ann Hematol"},{"issue":"8","key":"7709_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.15537\/smj.2021.42.8.20210236","volume":"42","author":"RS Gassas","year":"2021","unstructured":"Gassas RS, Absi AN, Alghamdi AA, Alsaeed AS, Alamoudi SM, Hemaidi IY, Alahmadi MD, Rajkhan WA, Khalil MM, Dadah SK, et al. Early infection in post-autologous hematopoietic stem cell transplant patients: Princess Noorah Oncology Center experience. Saudi Med J. 2021;42(8):847\u201352.","journal-title":"Saudi Med J"},{"issue":"3","key":"7709_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12185-021-03177-9","volume":"114","author":"I Danylesko","year":"2021","unstructured":"Danylesko I, Sareli R, Varda-Bloom N, Yerushalmi R, Shem-Tov N, Magen H, Shimoni A, Nagler A. Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation. Int J Hematol. 2021;114(3):363\u201372.","journal-title":"Int J Hematol"},{"key":"7709_CR19","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1182\/blood-2018-99-118554","volume":"132","author":"F Autore","year":"2018","unstructured":"Autore F, Piccirillo N, Nozza A, Innocenti I, Putzulu R, Chiusolo P, Sora F, Zini G, Bacigalupo A, Castagna L, et al. Which is the best mobilizing regimen in POEMS syndrome? A retrospective Italian study of two haematological centres. Blood. 2018;132:5692.","journal-title":"Blood"},{"issue":"6","key":"7709_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4103\/ijmr.IJMR_1593_18","volume":"149","author":"L Kumar","year":"2019","unstructured":"Kumar L, Ramavath D, Kataria B, Tiwari A, Raj A, Chellapuram SK, Mookerjee A, Sahoo RK, Malik PS, Sharma A, et al. High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: predictors of long-term outcome. Indian J Med Res. 2019;149(6):730\u20139.","journal-title":"Indian J Med Res"},{"key":"7709_CR21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fonc.2019.00892","volume":"9","author":"A Colita","year":"2019","unstructured":"Colita A, Colita A, Bumbea H, Croitoru A, Orban C, Lipan LE, Craciun OG, Soare D, Ghimici C, Manolache R, et al. LEAM vs. BEAM vs. CLV conditioning regimen for autologous stem cell transplantation in malignant lymphomas. Retrospective comparison of toxicity and efficacy on 222 patients in the first 100 days after transplant, on behalf of the Romanian society for bone marrow transplantation. Front Oncol. 2019;9:892.","journal-title":"Front Oncol"},{"issue":"7","key":"7709_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.bmt.1703389","volume":"29","author":"SN Wolff","year":"2002","unstructured":"Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant. 2002;29(7):545\u201352.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"7709_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bjh.14190","volume":"175","author":"HM Teltschik","year":"2016","unstructured":"Teltschik HM, Heinzelmann F, Gruhn B, Feuchtinger T, Schlegel P, Schumm M, Kremens B, M\u00fcller I, Ebinger M, Schwarze CP, et al. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients. Br J Haematol. 2016;175(1):115\u201322.","journal-title":"Br J Haematol"},{"issue":"6","key":"7709_CR24","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1016\/j.ijid.2009.08.006","volume":"14","author":"H Hof","year":"2010","unstructured":"Hof H. IFI = invasive fungal infections. What is that? A misnomer, because a non-invasive fungal infection does not exist! Int J Infecti Dis. 2010;14(6):e458-459.","journal-title":"Int J Infecti Dis"},{"issue":"1","key":"7709_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","volume":"55","author":"J Styczy\u0144ski","year":"2020","unstructured":"Styczy\u0144ski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):126\u201336.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"7709_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s15010-018-1200-y","volume":"46","author":"R Moghnieh","year":"2018","unstructured":"Moghnieh R, Abdallah D, Awad L, Jisr T, Mugharbil A, Youssef A, Tamim H, Khaldieh S, Massri O, Rashini N, et al. Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade\u2019s experience from Lebanon. Infection. 2018;46(6):823\u201335.","journal-title":"Infection"},{"issue":"1","key":"7709_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/tid.12165","volume":"16","author":"A Srinivasan","year":"2014","unstructured":"Srinivasan A, McLaughlin L, Wang C, Srivastava DK, Shook DR, Leung W, Hayden RT. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience. Transpl infectious Dis. 2014;16(1):90\u20137.","journal-title":"Transpl infectious Dis"},{"issue":"3","key":"7709_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1600-0609.2004.00273.x","volume":"73","author":"E Jantunen","year":"2004","unstructured":"Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, Kuittinen O, Leppa S, Anttila VJ, Itala M, et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol. 2004;73(3):174\u20138.","journal-title":"Eur J Haematol"},{"issue":"7","key":"7709_CR29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbmt.2013.04.027","volume":"19","author":"PL McCarthy Jr","year":"2013","unstructured":"McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, et al. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995\u20132005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. Biol Blood Marrow Transplant. 2013;19(7):1116\u201323.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"7709_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bbmt.2008.04.013","volume":"14","author":"LF Porrata","year":"2008","unstructured":"Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA, Litzow MR, Winters JL, Markovic SN. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant. 2008;14(7):807\u201316.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"7709_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1182\/blood.V98.3.579","volume":"98","author":"LF Porrata","year":"2001","unstructured":"Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood. 2001;98(3):579\u201385.","journal-title":"Blood"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07709-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07709-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07709-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:05:40Z","timestamp":1662548740000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07709-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7709"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07709-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in adherence to the international ethical principles and those in the Declaration of Helsinki. The study was approved by the Institutional Review Board of An-Najah National University. An-Najah National University Hospital approved this study. All patients provided written informed consents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"725"}}